News & Updates
Filter by Specialty:

Tirzepatide reduces weight in women with obesity across reproductive stages
09 May 2025
byStephen Padilla
Treatment with tirzepatide, compared with placebo, results in significant reductions in body weight, waist circumference, and waist-to-height ratio (WHtR) among women with obesity or overweight and without type 2 diabetes (T2D), regardless of reproductive stage.
Tirzepatide reduces weight in women with obesity across reproductive stages
09 May 2025
MARIPOSA update: Amivantamab-lazertinib may extend survival beyond 4 years in EGFRm NSCLC
09 May 2025
byAudrey Abella
In the protocol-specified final overall survival (OS) analysis of the phase III MARIPOSA trial, treatment with amivantamab plus lazertinib significantly reduced the risk of death in individuals with previously untreated EGFR-mutant (EGFRm) advanced non-small cell lung cancer (NSCLC).